Cargando…

Thiolated Mesoporous Silica Nanoparticles as an Immunoadjuvant to Enhance Efficacy of Intravesical Chemotherapy for Bladder Cancer

The characteristics of global prevalence and high recurrence of bladder cancer has led numerous efforts to develop new treatments. The spontaneous voiding and degradation of the chemodrug hamper the efficacy and effectiveness of intravesical chemotherapy following tumor resection. Herein, the extern...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Cheng‐Che, Fa, Yu‐Chen, Kuo, Yen‐Yu, Liu, Yi‐Chun, Lin, Chih‐Yu, Wang, Xin‐Hui, Lu, Yu‐Huan, Chiang, Yu‐Han, Yang, Chia‐Min, Wu, Li‐Chen, Ho, Ja‐an Annie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982584/ https://www.ncbi.nlm.nih.gov/pubmed/36638276 http://dx.doi.org/10.1002/advs.202204643

Ejemplares similares

Silica-based cationic bilayers as immunoadjuvants
por: Lincopan, Nilton, et al.
Publicado: (2009)

Influence of serum concentration and surface functionalization on the protein adsorption to mesoporous silica nanoparticles
por: Lin, Chih-Yu, et al.
Publicado: (2019)

Mesoporous gold nanospheres via thiolate–Au(i) intermediates
por: Lv, Hao, et al.
Publicado: (2019)

Efficacy of Intravesical Botulinum Toxin A Injection in the Treatment of Refractory Overactive Bladder in Children
por: Fan, Yu-Hua, et al.
Publicado: (2023)

Mesoporous Silica Nanoparticles for Protein Protection and Delivery
por: Xu, Chun, et al.
Publicado: (2019)

Mesoporous silica/organosilica nanoparticles for cancer immunotherapy
por: Theivendran, Shevanuja, et al.
Publicado: (2023)

Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy
por: Yu, Albert, et al.
Publicado: (2022)

A Hydrogel-Based Epirubicin Delivery System for Intravesical Chemotherapy
por: Liu, Ching-Wen, et al.
Publicado: (2016)

Hyperthermia as Adjunct to Intravesical Chemotherapy for Bladder Cancer
por: Owusu, Richmond A., et al.
Publicado: (2013)

Changes in the Ultrastructure of the Bladder Urothelium in Patients with Interstitial Cystitis after Intravesical Injections of Platelet-Rich Plasma
por: Lee, Yu-Khun, et al.
Publicado: (2022)

Rational Design of Mesoporous Silica (SBA-15)/PF (Phenolic Resin) Nanocomposites by Tuning the Pore Sizes of Mesoporous Silica
por: Liu, Hongxia, et al.
Publicado: (2022)

An Update on Mesoporous Silica Nanoparticle Applications in Nanomedicine
por: Rastegari, Elham, et al.
Publicado: (2021)

The Progress of Chitosan-Based Nanoparticles for Intravesical Bladder Cancer Treatment
por: Yu, Chong, et al.
Publicado: (2023)

Immunotherapy of Malignant Glioma by Noninvasive Administration of TLR9 Agonist CpG Nano‐Immunoadjuvant
por: Wei, Jingjing, et al.
Publicado: (2022)

Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis
por: Cao, Ruoqiong, et al.
Publicado: (2018)

Cationic and Biocompatible Polymer/Lipid Nanoparticles as Immunoadjuvants
por: Pérez-Betancourt, Yunys, et al.
Publicado: (2021)

Synthesis and cytotoxic analysis of thiolated xylose derivatives decorated on gold nanoparticles
por: Shiue, Angus, et al.
Publicado: (2020)

Systemic BCG‐osis following intravesical BCG instillation for bladder carcinoma
por: Liaw, Frank, et al.
Publicado: (2017)

Intravesical chemotherapy in non-muscle-invasive bladder cancer
por: Porten, Sima P., et al.
Publicado: (2015)

Disseminated BCG: Complications of Intravesical Bladder Cancer Treatment
por: To, Uyen, et al.
Publicado: (2014)

Intravenous chemotherapy combined with intravesical chemotherapy to treat T1G3 bladder urothelial carcinoma after transurethral resection of bladder tumor: results of a retrospective study
por: Zhang, Yu, et al.
Publicado: (2016)

Thiolated Chitosan as an Intestinal Absorption Carrier with Hesperidin Encapsulation for Obesity Treatment
por: Chen, Tzu-Chien, et al.
Publicado: (2021)

Efficacy of Bladder Intravesical Chemotherapy with Three Drugs for Preventing Non-Muscle-Invasive Bladder Cancer Recurrence
por: Zhang, Jianglei, et al.
Publicado: (2021)

Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis
por: Chen, Jing-Liang, et al.
Publicado: (2020)

Chitins and Chitosans as Immunoadjuvants and Non-Allergenic Drug Carriers
por: Muzzarelli, Riccardo A. A.
Publicado: (2010)

Chitosan-Functionalized Graphene Oxide as a Potential Immunoadjuvant
por: Yan, Ting, et al.
Publicado: (2017)

Multifunctional Immunoadjuvants for Use in Minimalist Nucleic Acid Vaccines
por: Abbasi, Saed, et al.
Publicado: (2021)

Liver cancer cells: targeting and prolonged-release drug carriers consisting of mesoporous silica nanoparticles and alginate microspheres
por: Liao, Yu-Te, et al.
Publicado: (2014)

Efficacy of Intra-Arterial Plus Intravesical Chemotherapy for High-Risk Non-Muscle-Invasive Bladder Cancer: A Pooled Analysis
por: Cheng, Chunliang, et al.
Publicado: (2021)

Bromocresol Green/Mesoporous Silica Adsorbent for Ammonia Gas Sensing via an Optical Sensing Instrument
por: Chang, Yu-Chang, et al.
Publicado: (2011)

Mucoadhesive Cationic Polypeptide Nanogel with Enhanced Penetration for Efficient Intravesical Chemotherapy of Bladder Cancer
por: Guo, Hui, et al.
Publicado: (2018)

Aqueous Cu(ii) ion adsorption by amino-functionalized mesoporous silica KIT-6
por: Wei, Jianwen, et al.
Publicado: (2020)

Treatment Outcomes of Intravesical Botulinum Toxin A Injections on Patients with Interstitial Cystitis/Bladder Pain Syndrome
por: Yu, Wan-Ru, et al.
Publicado: (2022)

The Efficacy of Intra-Arterial Plus Intravesical Chemotherapy Versus Intravesical Chemotherapy Alone After Bladder-Sparing Surgery in High-Risk Bladder Cancer: A Systematic Review and Meta-Analysis of Comparative Study
por: Zhou, Zhongbao, et al.
Publicado: (2021)

Preclinical analyses of intravesical chemotherapy for prevention of bladder cancer progression
por: Delto, Joan C., et al.
Publicado: (2013)

Biosafety of mesoporous silica nanoparticles: a combined experimental and literature study
por: Sun, Lue, et al.
Publicado: (2021)

Intravesical Treatments of Bladder Cancer: Review
por: Shen, Zancong, et al.
Publicado: (2008)

Intravesical therapy for urothelial carcinoma of the bladder
por: Manoharan, M.
Publicado: (2011)

Hollow Mesoporous Silica@Zeolitic Imidazolate Framework Capsules and Their Applications for Gentamicin Delivery
por: Xu, Xiaoxiang, et al.
Publicado: (2018)

Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis—Different Mechanisms of Action of Botox on Bladder Dysfunction?
por: Kuo, Yuh-Chen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0989vnoau5r88tr255kgd1vn2i